Pfizer coronavirus (COVID-19) vaccine could obtain reg 174 approval says MHRA

Pfizer coronavirus (COVID-19) vaccine could obtain reg 174 approval says MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a statement, following the very encouraging’ results reported by Pfizer on its potential coronavirus (COVID-19) vaccine. The MHRA has stated that it may approve the potential vaccine’s use via a temporary authorisation route known as regulation 174, as well as through the full marketing authorisation procedure. MHRA scientists and clinicians will review the safety, quality and effectiveness data before seeking advice from the government’s independent advisory body, the Commission on Human Medicines.

The Commission on Human Medicine will assess the data and advise the government on the safety, quality and effectiveness of any potential vaccine. Once the MHRA approves a vaccine, the Joint Committee on Vaccination and Immunisation will advise the government on the use of the vaccine.

Source: Pfizer / BioNTech COVID-19 vaccine: MHRA statement

Subscription Form

Related Articles:
Latest Articles:

Access this article and thousands of others like it free by subscribing to our blog.

Read full article

Already a subscriber? Login